Can You Take a GLP-1 Medication While Pregnant or Trying to Conceive?

What this means

The hair loss reported with GLP-1 medications is mostly telogen effluvium, a diffuse shedding of resting hairs that follows a physical stress. Common triggers include crash dieting, low protein intake, iron deficiency, thyroid disease, illness and surgery (Hughes et al., 2024). Large or fast weight loss is itself such a stress, which makes it hard to separate the effect of the medication from the effect of the weight change.

Shedding usually starts about 3 months after the trigger, with a range of 1 to 6 months, so hair loss can appear well after the first dose or after most of the weight is gone. The condition is not scarring, and hair generally regrows once the trigger is addressed, although regrowth can take up to 6 months to begin and longer to become visible (Hughes et al., 2024).

Candidacy

Hair shedding is not a reason on its own to rule out a GLP-1 medication, and it does not happen to everyone. A 2026 review found that risk may be higher with higher obesity-dose regimens, rapid or large weight loss, and in women, though the authors note reporting bias may explain part of the sex difference (Gupta et al., 2026). A physician may check for iron deficiency, thyroid disease and low protein intake before and during a weight-loss program, especially with a history of hair thinning. Whether a GLP-1 medication fits you is decided after a physician evaluation.

Clinical evaluation

A physician looking at hair shedding during weight loss should review:

• Timing. When the shedding started relative to the first dose, dose increases and the pace of weight loss.
• Pattern. Even thinning across the scalp points to shedding. Patchy loss, a widening part or scarring signs point to other causes that need a dermatology visit.
• Nutrition. Daily protein, total calories and any restrictive eating.
• Labs. Thyroid function and iron status, including ferritin, are the usual first tests (Hughes et al., 2024).
• Other triggers. Recent illness, surgery, childbirth, stopped hormones and other medications.

Available options

When shedding is linked to weight loss, the usual approach is to look for correctable contributors and give hair time. That can mean adjusting protein intake, correcting low iron or thyroid levels, and slowing the pace of weight loss when appropriate, which a physician decides with you. Do not stop or change a prescribed medication on your own because of shedding. Talk with the prescriber first. Persistent shedding past about 6 months, patchy loss or scalp symptoms call for a dermatology evaluation.

Benefits, limitations and risks

The practical limit is that no one can promise how a given person will respond. Hair loss is a recognized side effect, but most users do not report it, and the shedding is usually temporary. The risk of ignoring it is missing a fixable cause such as low iron or a thyroid problem. The risk of overreacting is stopping a medication that was working for other health reasons without a plan.

These FDA label figures come from approved products. Products that are not FDA-approved have not been through the same trials, so the same numbers cannot be assumed to apply to them. Individual results vary.

What the evidence shows

What it establishes: In the Wegovy label, hair loss was reported by 3% of adults on 2.4 mg versus 1% on placebo, and by 4% versus 0% in adolescents 12 and older (Novo Nordisk, 2025). A systematic review of 24 studies reported alopecia in about 5% of people across tirzepatide doses versus 0.9% on placebo in the SURMOUNT-1 trial, and 7% versus 1.4% in SURMOUNT-3. A pooled analysis of randomized trials found a relative risk of 3.40 (95% CI 1.18 to 9.81), with high variability between studies (Gupta et al., 2026).

What it does not establish: that the medication itself causes hair loss. The review's authors say most included studies are retrospective or small, reports from safety databases show disproportion rather than true incidence, and weight loss and nutritional deficiency may be the main drivers (Gupta et al., 2026). The hair loss described was mainly non-scarring, either telogen effluvium or pattern hair loss.

Recovery and next steps

If shedding starts, note when it began and how much weight you have lost, and bring your current medication doses and recent lab results to the next visit. Most shedding episodes settle within months, and regrowth is gradual. Call the office sooner for patchy bald spots, scalp pain or redness, or shedding that continues beyond about 6 months. Individual results vary.